
RETATRUTIDE
A synthetic triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, studied in metabolic and endocrine research for its effects on energy-regulation pathways.
- FORMAT
- LYOPHILIZED VIAL
- SIZES
- MULTIPLE — INQUIRE
FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.


CONTACT →




